Abulhasan Sheikh

Yonsei University

Papers

3

Total Citations

101

H-Index

3

About

Dr. Abulhasan Sheikh is a leading urologic surgeon and researcher whose work centers on advancing robot-assisted surgical techniques for complex renal and upper tract pathologies. His primary research areas include the optimization of partial nephrectomy outcomes, comparative effectiveness of robotic platforms, and expanding minimally invasive options for high-risk patients. Dr. Sheikh’s major contributions are exemplified by his landmark study on high-complexity renal tumors (PADUA score ≥10), which demonstrated that robot-assisted partial nephrectomy can achieve favorable trifecta outcomes and long-term oncological control even in the most challenging cases, with a median follow-up of 46.5 months. This work, cited 49 times, has helped redefine surgical boundaries. He also provided critical evidence that the Da Vinci Xi and Si platforms yield equivalent perioperative outcomes, offering flexibility in surgical planning. Additionally, his pioneering work on robot-assisted segmental ureterectomy and ureteroureterostomy established a feasible, nephron-sparing alternative for patients with high medical comorbidity, expanding treatment options for those previously deemed poor surgical candidates. With over 100 cumulative citations, Dr. Sheikh’s research continues to shape evidence-based practice in robotic urologic oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
101
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of high‐complexity renal tumours with a Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) score of ≥10 after robot‐assisted partial nephrectomy with a median 46.5‐month follow‐up: a tertiary centre experience
49 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Yonsei University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago